Page 8 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

11 Most Promising Psychedelic Stocks According to Hedge Funds

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.

San franciscoUnited statesHal mintz sabbyJohns hopkinsEgen atkinsonJohn overdeckMichael kramarz commodoreColumbia universityMount sinai medical schoolMark lampert biotechnology value fundGh researchCellular therapies incNrx pharmaceuticals incSage therapeutics incSeelos therapeutics incAtai life sciences

Latest biotech news: fundraises, deals, clinical trials

What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

United statesSouth koreaAl iskandariyahGreat pointUnited kingdomBristol myers squibbFreya biosciencesAbelzeta pharmaTezcat biosciencesAnn roberth lurieAndreessen horowitzYi zhuDrug administrationGrossman school of medicineLife sciencesNovo holdings

Akero Therapeutics, Inc (NASDAQ:AKRO) Director Purchases $1,983,000 00 in Stock

Akero Therapeutics, Inc (NASDAQ:AKRO) Director Purchases $1,983,000 00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

G walmsley grahamAkero therapeutics incMorgan stanleyPerceptive advisorsPricet rowe associates incJpmorgan chase coAkero therapeuticsGet free reportWalmsley grahamCommodore capitalAkero therapeutics daily

Commodore Capital LP Has $52 26 Million Holdings in Ambrx Biopharma Inc (NYSE:AMAM)

Commodore Capital LP lowered its position in shares of Ambrx Biopharma Inc. (NYSE:AMAM – Free Report) by 33.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,175,000 shares of the company’s stock after selling 1,628,447 shares during the period. […]

Ambrx biopharmaSonja nelsonCantor fitzgeraldRoyal bankAmbrx biopharma incB riley wealth advisors incSecurities exchange commissionSquarepoint opsAmbrx biopharma company profileRenaissance technologiesGoldman sachs groupCommodore capitalFree reportWealth advisorsExchange commissionCormorant asset management

Akero Therapeutics, Inc (NASDAQ:AKRO) Shares Purchased by Commodore Capital LP

Commodore Capital LP boosted its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,675,000 shares of the company’s stock after acquiring an additional 885,000 shares during the quarter. Akero Therapeutics accounts […]

Catriona yaleAndrew chengSwiss national bankVanguard group incAkero therapeutics incMorgan stanleyCantor fitzgeraldJpmorgan chase coSecurities exchange commissionMetlife investment managementExchange commissionYork mellon corpDimensional fund advisorsCommodore capitalAkero therapeuticsFree report